Research Triangle Park, NC – Technology Commercialization Group, LLC (TCG), an international life science consulting firm specializing in interim management and strategic transaction services, is pleased to announce that Michael Garrett has joined the firm as a new Partner. Mr. Garrett has over 25 years of senior-level business development, licensing, legal and finance experience at Aventis, BTG, Pharmavent and ICI.  Over his career, Mr. Garrett has played key roles in over 25 transactions, ranging from structuring company spinouts from pharmaceutical and university technologies through to execution of multi-million dollar transactions involving large multi-national companies.  Most recently, he was Vice President of Scynexis, Inc. where he was part of the management team that completed a $62 million IPO in summer 2014.

“Mike’s experience working in Europe and US with mid-size and large corporations fits perfectly with TCG’s approach to working with clients on both continents.” commented Ken West, Managing Partner of TCG. “The continued increase in M&A deals in both the Pharmaceutical and Medical Device industries means that more clients are seeking our help in executing strategic transactions. Mike’s broad range of transactional, financial and legal knowledge complements and deepens TCG’s offering to its clients,” Mr. West added.

“I am delighted to join the TCG team,” said Mr. Garrett. “The firm’s track record in supporting companies seeking to build their US businesses and execute strategic transactions is unique in the industry. I look forward to working as a part of the TCG team to continue building value for our pharmaceutical and biotechnology clients.”